Postpones Release 4th Quarter and Fiscal Year 2017 Financial Results

MiMedx Postpones Release of its Fourth Quarter and Fiscal Year 2017 Financial Results

MARIETTA, Ga., Feb. 20, 2018 /PRNewswire/ — MiMedx Group, Inc. (NASDAQ: MDXG), a leading developer and marketer of regenerative and therapeutic biologics,…